Novem Group Bristol Myers Squibb CO Call Options Transaction History
Novem Group
- $713 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BMY
# of Institutions
2,800Shares Held
1.59BCall Options Held
25.8MPut Options Held
23.7M-
Vanguard Group Inc Valley Forge, PA191MShares$8.77 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.27 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.95 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.34 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.04 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...